E-LIB Suche - Ergebnisse für: Gainor, J.F.

1

Long-term survival with first-line nivolumab plus ipilimuma..:

Borghaei, H. ; Ciuleanu, T.-E. ; Lee, J.-S....
Annals of Oncology. 34 (2023) 2 - p. 173-185 , 2023

Link: https://doi.org/10.1016/..

2

Safety and efficacy of pralsetinib in RET fusion–positive n..:

Griesinger, F. ; Curigliano, G. ; Thomas, M....
Annals of Oncology. 33 (2022) 11 - p. 1168-1178 , 2022

Link: https://doi.org/10.1016/..

3

Safety and activity of alectinib plus bevacizumab in patien..:

Lin, J.J. ; Muzikansky, A. ; Kennedy, E....
ESMO Open. 7 (2022) 1 - p. 100342 , 2022

Link: https://doi.org/10.1016/..

4

KEYLYNK-012: A Phase 3 Study of Pembrolizumab With Concurre..:

Jabbour, S.K. ; Cho, B.C. ; Bria, E....
International Journal of Radiation Oncology*Biology*Physics. 111 (2021) 3 - p. e440-e441 , 2021

Link: https://doi.org/10.1016/..

5

Clinical activity of programmed cell death 1 (PD-1) blockad..:

Gainor, J.F. ; Rizvi, H. ; Jimenez Aguilar, E....
Annals of Oncology. 31 (2020) 3 - p. 404-411 , 2020

Link: https://doi.org/10.1016/..

6

Mechanisms of resistance to selective RET tyrosine kinase i..:

Lin, J.J. ; Liu, S.V. ; McCoach, C.E....
Annals of Oncology. 31 (2020) 12 - p. 1725-1733 , 2020

Link: https://doi.org/10.1016/..

7

Outcomes to first-line pembrolizumab in patients with non-s..:

Aguilar, E.J. ; Ricciuti, B. ; Gainor, J.F....
Annals of Oncology. 30 (2019) 10 - p. 1653-1659 , 2019

Link: https://doi.org/10.1093/..

8

Significance of targeted therapy and genetic alterations in..:

Mak, K. S. ; Gainor, J. F. ; Niemierko, A....
Neuro-Oncology. 17 (2014) 2 - p. 296-302 , 2014

Link: https://doi.org/10.1093/..

9

Acquired Resistance to Afatinib in EGFR-Mutant Lung Cancer:

Sequist, L.V. ; Gerber, D.E. ; Fidias, P....
International Journal of Radiation Oncology*Biology*Physics. 90 (2014) 5 - p. S43-S44 , 2014

Link: https://doi.org/10.1016/..

10

Variation in Mechanisms of Acquired Resistance Among EGFR-M..:

Piotrowska, Z. ; Niederst, M.J. ; Mino-Kenudson, M....
International Journal of Radiation Oncology*Biology*Physics. 90 (2014) 5 - p. S6-S7 , 2014

Link: https://doi.org/10.1016/..

11

Radiation Therapy for Brain Metastases in Non-Small Cell Lu..:

Mak, K.S. ; Gainor, J.F. ; Niemierko, A....
International Journal of Radiation Oncology*Biology*Physics. 87 (2013) 2 - p. S51 , 2013

Link: https://doi.org/10.1016/..

12

Three-year overall survival outcomes and correlative analys..:

Ricciuti, Biagio ; Elkrief, Arielle ; Lin, Jessica...
JTO Clinical and Research Reports. , 2024

Link: https://doi.org/10.1016/..

13

Identifying MAGE-A4-positive tumors for TCR T cell therapie..:

Wang, Tianjiao ; Navenot, Jean-Marc ; Rafail, Stavros...
Molecular Therapy - Methods & Clinical Development. 32 (2024) 2 - p. 101265 , 2024

Link: https://doi.org/10.1016/..

14

Sarcopenia, adiposity and large discordance between cystati..:

Hanna, Paul E. ; Ouyang, Tianqi ; Tahir, Ismail...
Journal of Cachexia, Sarcopenia and Muscle. 15 (2024) 3 - p. 1187-1198 , 2024

Link: https://doi.org/10.1002/..

15

Dynamic heterogeneity in COVID-19: Insights from a mathemat..:

Voutouri, Chrysovalantis ; Hardin, C. Corey ; Naranbhai, Vivek...
PLOS ONE. 19 (2024) 5 - p. e0301780 , 2024

Link: https://doi.org/10.1371/..